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Abstract
Temozolomide (TMZ) is an alkylating agent used for treating gliomas. Chemoresistance is a severe limitation to TMZ
therapy; there is a critical need to understand the underlying mechanisms that determine tumor response to TMZ. We
recently reported that chemoresistance to TMZ is related to a remodeling of the entire electron transport chain, with
significant increases in the activity of complexes II/III and cytochrome c oxidase (CcO). Moreover, pharmacologic and
genetic manipulation of CcO reverses chemoresistance. Therefore, to test the hypothesis that TMZ-resistance arises from
tighter mitochondrial coupling and decreased production of reactive oxygen species (ROS), we have assessed mitochondrial
function in TMZ-sensitive and -resistant glioma cells, and in TMZ-resistant glioblastoma multiform (GBM) xenograft lines
(xenolines). Maximum ADP-stimulated (state 3) rates of mitochondrial oxygen consumption were greater in TMZ-resistant
cells and xenolines, and basal respiration (state 2), proton leak (state 4), and mitochondrial ROS production were
significantly lower in TMZ-resistant cells. Furthermore, TMZ-resistant cells consumed less glucose and produced less lactic
acid. Chemoresistant cells were insensitive to the oxidative stress induced by TMZ and hydrogen peroxide challenges, but
treatment with the oxidant L-buthionine-S,R-sulfoximine increased TMZ-dependent ROS generation and reversed
chemoresistance. Importantly, treatment with the antioxidant N-acetyl-cysteine inhibited TMZ-dependent ROS generation
in chemosensitive cells, preventing TMZ toxicity. Finally, we found that mitochondrial DNA-depleted cells (ru) were resistant
to TMZ and had lower intracellular ROS levels after TMZ exposure compared with parental cells. Repopulation of ru cells
with mitochondria restored ROS production and sensitivity to TMZ. Taken together, our results indicate that
chemoresistance to TMZ is linked to tighter mitochondrial coupling and low ROS production, and suggest a novel
mitochondrial ROS-dependent mechanism underlying TMZ-chemoresistance in glioma. Thus, perturbation of mitochondrial
functions and changes in redox status might constitute a novel strategy for sensitizing glioma cells to therapeutic
approaches.
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Introduction
Mitochondria are cellular organelles that play central roles in
energy metabolism, retrograde signaling, and apoptosis. Within the
mitochondria, oxidative phosphorylation (OxPhos) couples ATP
production to the flow of electrons through the electron transport
chain (ETC). Electron flow through the ETC occurs by the transfer
of electrons through a chain of protein substrates (complexes I-IV).
Upon reduction of the substrates, protons are released and a proton
gradientisgenerated acrosstheinnermitochondrialmembranethat
serves as the electrochemical energy gradient necessary for ADP
phosphorylation. Low electron flux through the ETC can promote
increased generation of superoxide radicals (O2
2), particularly at
complexes I and III [1,2]. It has been reported that O2
2 is
generated constantly during cellular metabolism [3] and can be
converted to hydrogen peroxide (H2O2) and other reactive oxygen
species (ROS). Mitochondria are considered the major source of
cellular ROS, which are intimately associated with retrograde
signaling and affect many cellular functions [4–6]. Most cancer cells
are under oxidative stress associated with increased metabolic
activity and productionof highlevels of ROS. ROS generation may
enhance the neoplastic behavior of a tumor by increasing genetic
instability and the capacity to invade host tissues [7]. Although
increased ROS production plays an important role in maintaining a
cancer phenotype due to stimulatory effects on cell growth and
proliferation [8], high levels of ROS can also cause cellular damage
including lipid peroxidation, DNA and protein oxidation, and
enzyme inactivation [5]. In general, cancer cells are metabolically
active, produce high levels of ROS, and are under intrinsic
oxidative stress, so they are more vulnerable to further oxidative
stress by exogenous ROS-generating agents [5,7,9–13]. In partic-
ular, and relevant to this study, it was recently demonstrated that
TMZ induces ROS production in gliomas as a result of DNA-
damage [14].
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in Warburg’s original studies. He postulated that the origin of
cancer was due to irreversible damage to mitochondrial function,
leading to enhanced glycolysis [15–17]. It has been suggested that
the mitochondrial injury in cancer cells leads to a lower coupling
efficiency of mitochondrial electron transport and ATP produc-
tion, along with increased electron leakage and ROS generation
during respiration, converting the mitochondrial respiration chain
in cancer cells to a potential target for cancer therapy [5].
We hypothesized that the TMZ-tolerance of chemoresistant
cells derives from tighter mitochondrial coupling and reduced
ROS production. To test this hypothesis, we investigated the
mitochondrial oxidative capacity of glioma cells and the ability of
TMZ to induce oxidative stress. For these studies, we used a TMZ-
resistant strain of U251 glioma cells (UTMZ), derived by selection
for resistance to stepwise increases of TMZ concentrations. The
ETC is remodeled dramatically in these TMZ-resistant cells; in
particular, the activity of complex I is reduced and the activities of
complexes II-III and cytochrome c oxidase (CcO or complex IV)
are increased [18]. We also used different cellular models of
mitochondrial dysfunction (ru cells, transmitochondrial cybrids
and CcO knockout cells) and pharmacological approaches to
investigate the role of mitochondrial ROS (mtROS) on the
modulation of TMZ sensitivity.
Results
TMZ-resistant glioma cells have higher respiratory rates
and tighter mitochondrial coupling
As an index of the mitochondrial functional capacity in TMZ-
resistant and –sensitive cells, we measured the rate of oxygen (O2)
consumption in intact mitochondria treated with 10 mM gluta-
mate and 5 mM malate (complex I substrates) (Fig. 1A and B).
The respiratory control ratio (RCR) (State 3/State 4) and acceptor
control ratio ACRolig (State 3/State 4i; the respiratory control
ratio calculated after inhibiting ATP synthase using oligomycin
[State 4i]) were measured as indicators of mitochondrial coupling.
The RCR values were 4.5960.96 and 1.2960.12 for UTMZ and
U251 cells, respectively. The ACRolig value was 4.7260.97 for
UTMZ cells and 1.3860.20 for U251 cells. Estimates were always
greater for mitochondria from UTMZ cells, indicating that these
mitochondria were highly coupled compared with mitochondria
from the parental, TMZ-sensitive cells. The comparatively lower
performance of mitochondria from U251 cells was due mainly to
the decline of state 3 respiration, but the increase of states 2 and 4
respiration contributed, as well (Fig. 1A and C).
Maximal electron flux through the ETC was measured in the
presence of the protonophore carboylcyanide-4-(trifluoromethoxy)-
phenylhydrazone (FCCP), which causes dissipation of the proton
gradient by carrying protons across the inner mitochondrial
membrane. Dissipation of the proton gradient by FCCP leads to
a rapid depolarization of mitochondria and acceleration of the flux
of electrons through the transport chain. This resulted in
significantly higher mitochondrial oxidative capacity in UTMZ
cells. Inhibition of complexes I and III with rotenone and antimycin
A, respectively, indicate a higher non-mitochondrial respiration in
U251 compared to UTMZ cells (Fig. 1C).
Previously, we described a panel of serially transplantable GBM
xenograft lines established by direct subcutaneous injection of
patient tumor tissue in the flank of nude mice [18]. To distinguish
these tumors from those induced in immunocompromised mice
using established tumor cell lines maintained in culture, we have
designatedtheseas‘‘xenolines.’’To evaluatetheclinicalsignificance
of our findings, we assessed the function and capacity of
mitochondria from TMZ-sensitive and -resistant xenolines. The
TMZ-resistant xenoline mitochondria have a higher maximum
ADP-stimulated (State 3) O2 consumption rate and decreased
respirationinstates2and4(lowerprotonleak)whencomparedwith
the TMZ-sensitive line (Fig. 1D). RCR (5.7460.56 vs. 1.3560.15)
and ACRolig (10.4660.69 vs. 260.45) indicated a tighter mito-
chondrial coupling in the TMZ-resistant xenograft line (Fig. 1D).
TMZ-resistant cells show reduced glucose consumption
and lactic acid production
The high efficiency of mitochondrial metabolism (Fig. 1) in
UTMZ cells might be reflected in a lower glycolytic rate. Figure 2A
and B shows that both glucose consumption and lactate
production are lower in UTMZ than in U251 glioma cells.
Lineweaver-Burk and Eadie-Hofstee analysis yielded similar
results. The Vmax for glucose consumption in UTMZ cells was
significantly lower than the Vmax in U251 cells (Table 1). The
Km for glucose in both cell lines was not significantly different.
This Km is close to the expected Km for GLUT3 (Km,1 mM)
[19,20], and is consistent with our previous report indicating that
U251 express GLUT3 on the cell surface [19], and might suggest
that both cell lines express similar glucose transporters on their cell
surface. Further, the rate of lactate formation was nearly 2-fold
lower in the UTMZ cells than in the U251 cells (Fig. 2B). These
results suggest that UTMZ are less glycolytic than the TMZ-
sensitive U251 cells, indicating less of the Warburg effect.
TMZ-resistant cells exhibit decreased ROS production
The significant differences in state 2 and state 4 respiration in
the mitochondria of these two cell models (Fig. 1) suggests possible
changes in the production of ROS. To examine this, we measured
acute mitochondrial O2
2 formation by fluorescence microscopy
and flow cytometry using MitoSOX Red, a fluoroprobe that
selectively detects O2
2 in mitochondria of live cells [21]. Both
analyses demonstrated that treatment with TMZ caused increases
in mitochondrial steady-state levels of O2
2 in U251 cells (Fig. 3A,
B and C). Since MitoSOX Red is relatively insensitive to oxidation
by H2O2, H2O2
2 or vehicle-treated cells were used as negative
controls (Fig. 3A). Quantitative analysis indicated that the steady-
state production of mitochondrial O2
2 by UTMZ cells is
substantially lower than that of U251 cells (Fig. 3A, B and C).
In additional experiments, changes in total ROS production
were estimated using CM-DCFDA, a cell-permeable probe that is
non-fluorescent when chemically reduced but fluoresces after
cellular oxidation and removal of acetate groups by cellular
esterases. As shown in Figure 4A and B, H2O2 and TMZ
challenges had no effect on the steady-state production of ROS by
UTMZ cells, but increased total ROS production in U251 cells by
18-fold (H2O2) and 10-fold (TMZ). These results also indicate that
the steady-state production of ROS by UTMZ cells is substantially
lower than that of U251 cells.
Overall, the data from these studies (Fig. 3 and 4) indicate that
treatment with pro-oxidants cause significant increases in
intracellular steady-state levels of ROS (i.e., O2
2 and H2O2)i n
U251 glioma cells. However, ROS generation by UTMZ cells was
markedly lower. In addition, the studies using MitoSOX Red
strongly support the hypothesis that mitochondria represent a
major source for increased steady-state levels of O2
2 in TMZ-
sensitive glioma cells.
TMZ-resistant cells exhibit decreased oxidative stress
Reduced glutathione (GSH) is an intracellular anti-oxidant
known to maintain cellular redox balance. We therefore measured
Mitochondrial Function and Chemoresistance
PLoS ONE | www.plosone.org 2 September 2011 | Volume 6 | Issue 9 | e24665Figure 1. TMZ-resistant cells show a higher mitochondrial coupling. Oxygen consumption rates of isolated mitochondria (200 mg) were
determined using a respirometer. Graphic illustrations of sample traces of mitochondrial respiration rates of (A) U251 and (B) UTMZ cells (dotted line,
oxygenconcentration; solidline,oxygenconsumption).(C)Kineticcharacterization ofglutamate/malate-dependentrespirationofisolatedmitochondria
from U251 and UTMZ cells. (D) Kinetic characterization of glutamate/malate-dependent respiration of isolated mitochondria from TMZ-sensitive and
resistant GBM xenolines. Data are expressed as means 6 S.E. of three independent experiments. p,0.05 (*), p,0.01 (**) and p,0.001 (***).
doi:10.1371/journal.pone.0024665.g001
Figure 2. Glucose uptake and lactate production in U251-MG and UTMZ cells. (A) Dose-response analyses of glucose uptake. (B) Time
course of lactate production. Data are shown as the means 6 S.E. of two independent experiments performed in triplicate.
doi:10.1371/journal.pone.0024665.g002
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glutathione (GSSG). H2O2 treatment did not produce a significant
change in the GSH/GSSG ratio in TMZ-resistant UTMZ cells
(Fig. 5A). However, there was a significant decrease in the GSH/
GSSG ratio (2-fold) in U251 cells after exposure to 100 mMH 2O2
for 1 h. Additionally, UTMZ cells had a significantly elevated (1.6-
fold) GSH/GSSG ratio under basal conditions, suggesting an
enhanced anti-oxidant capacity.
Mitochondrial lipid peroxidation, a downstream marker of
oxidative damage, was examined using nonyl acridine orange
(NAO) staining to detect oxidation of cardiolipin using flow
cytometry. Cardiolipin is a membrane lipid component exclusively
present in mitochondria that fluoresces yellow when labeled with
NAO, [5,22]. UTMZ cells were completely resistant to cardiolipin
oxidation by TMZ, and H2O2-induced cardiolipin oxidation in
UTMZ cells was significantly lower than in U251 cells treated
Table 1. Kinetic analysis of glucose uptake in TMZ-sensitive
and TMZ-resistant glioma cells.
Vmax (nmoles/h/mg) Km (mM)
U251 UTMZ U251 UTMZ
Lineweaver-Burk 1.06460.077 0.35060.06
a 1.0560.075 1.1160.038
b
Eadie-Hofstee 1.17660.12 0.37660.01
a 1.1360.065 1.3260.026
b
Results are expressed as mean 6 SE. (n=3 separate determinations).
ap,0.01;
bp value no significative. Statistical analysis was performed using Student’s two-
tailed t test.
doi:10.1371/journal.pone.0024665.t001
Figure 3. Determination of mitochondrial superoxide production. ROS production was estimated by oxidation of the fluorescent probe,
MitoSox in TMZ-sensitive (U251) and TMZ-resistant (UTMZ) cells after 2 h of treatment with vehicle (control), H2O2 (100 mM) or TMZ (300 mM). (A)
Representative histograms of flow cytometric analysis of MitoSox fluorescence. (B) Columns represent the MitoSox-mean fluorescence. Data are
expressed as means 6 S.E. of three independent experiments. p,0.05 (*). (C) Representative images acquired with epifluorescence microscopy
showing co-localization of Mito Tracker Green and MitoSox fluorescence in U251 (Top panel) and UTMZ cells (Bottom panel).
doi:10.1371/journal.pone.0024665.g003
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fluorescence towards the left (Fig. 5C, D and E).
To examine the differences in intracellular ROS production by
U251 and UTMZ cells further, we measured the generation of
apurinic/apyrimidinic (AP) sites in mitochondrial DNA (mtDNA)
following treatment with 100 mMH 2O2 for 1 h. AP sites are one
of the major types of DNA lesions formed during the course of
base excision and repair of oxidized, deaminated or alkylated
bases [23], so the number of AP sites in cells is a good indicator of
DNA lesion and repair against oxidative damage [23]. As shown
in Figure 5B, UTMZ cells showed no significant change in
generation of mitochondrial AP sites. In contrast, the number of
mitochondrial AP sites increased significantly in U251 cells after
H2O2 challenge.
Mitochondrial ROS regulate TMZ-resistance
Because UTMZ cells have a higher threshold for induction of
O2
2, we examined whether increased mitochondrial ROS would
reverse TMZ resistance in chemoresistant glioma cells. Figure 6A
shows mitochondrial ROS production in different cellular models.
TMZ-resistant UTMZ cells were depleted of CcO (COXIV-1-
shRNA) [18] and used as a model of decreased oxidative capacity.
COXIV-1 shRNA cells exposed to 300 mM TMZ showed a
significant increase in mitochondrial O2
2 levels compared with
empty vector-transfected UTMZ cells (pLKO.1) (Fig. 6A). More-
over, treatment with TMZ increased the percentage of annexin V-
positive cells (apoptotic cells) in the COXIV-1 shRNA-transfected
UTMZ cells, but did not affect the percentage of annexin V-
positive cells in UTMZ cells transfected with the empty vector
(pLKO.1) (Fig. 6B).
We also compared the effect of TMZ treatment on mtROS
production using U251 cells, mtDNA-depleted U251 cells (U251
ru cells) and transmitochondrial cybrids [24] (U251-ru cells
repopulated with parental (U251) mtDNA) (Fig. 6A). U251-ru cells
were used as a genetic model of non-functional mitochondria. In
the absence of TMZ, all isogenic cell lines generated small
amounts of mtROS. TMZ-treatment did not increase ROS
production in mtDNA-depleted U251-ru cells, but enhanced
production of mtROS in the parental U251 cells and the trans-
mitochondrial cybrids (Fig. 6A). After incubation with TMZ, the
percentage of annexin V-positive cells increased in U251 and
cybrid cell lines but not in U251-ru cells (Fig. 6B).
To test further whether ROS are involved in TMZ-dependent
induction of apoptosis, U251 and UTMZ glioma cells were
incubated with N-acetylcysteine (NAC), a thiol anti-oxidant, or L-
buthionine-S,R-sulfoximine (BSO), an inhibitor of glutathione
synthesis, and subsequently analyzed for TMZ-dependent apop-
tosis. As shown in Figure 7A, co-treatment with TMZ (300 mM)
and BSO (5 mM) increased the percentage of apoptotic U251 cells
compared with untreated or BSO-treated cells. Exposure of
UTMZ cells to BSO did not induce a significant change in the
percentage of apoptotic cells. However, co-treatment with TMZ
and BSO caused a significant increase in the percentage of
apoptotic cells. Next, we examined the effects of NAC (5 mM) on
TMZ-dependent apoptosis. As shown in Figure 7A, NAC
effectively prevented TMZ-induced apoptosis in U251 cells and
had no additional effect in UTMZ cells. These findings
demonstrate that perturbation of mitochondrial functions and
changes in redox status are important components in the
mechanism of TMZ-induced cell death.
Discussion
GBM is the most frequent form of high grade malignant brain
tumor. Since the study by Stupp et al. in 2005, the standard
treatment for patients with primary GBM has included a regimen
of concomitant and adjuvant chemotherapy with temozolomide
(TMZ) [25,26]. TMZ is an orally bioavailable alkylating agent that
is known to target nuclear DNA and generate nuclear DNA
adducts that block the cell cycle and lead to cell death through
apoptosis. While the chemotherapeutic regimen is commonly used
as part of the treatment against GBM and can be advantageous for
short periods of time, chemotherapy is eventually impaired by the
development of chemoresistance. This phenomenon represents the
most challenging problem in the successful treatment of cancer
and is the main reason for chemotherapy failure.
Our previous data showed a dramatic remodeling of the ETC in
TMZ-resistant glioma cells. Of particular interest is the significant
increase in CcO activity in the TMZ-resistant cell models and
GBM patient biopsies taken after treatment and at the time of
recurrence. We tentatively concluded that TMZ-resistant glioma
cells, through an adaptive remodeling of the ETC activities, may
have developed more efficient coupling between electron transport
and ATP production, which enhanced the ability to increase
mitochondrial electron transport during conditions of bioenergetic
demand, conferring a selective advantage during the progression
of the tumor. We proposed that modulation of the regulation of
bioenergetics in the cancer cell plays an essential role in tumor
progression after failure of chemotherapy [18].
Our present results indicate that chemoresistance to TMZ is
due to more efficient mitochondrial coupling and reduced ROS
Figure 4. Determination of total ROS production. ROS produc-
tion was estimated by oxidation of the fluorescent probe, CM-CFDA
in TMZ-sensitive (U251) and TMZ-resistant (UTMZ) cells after 2 h of
treatment with vehicle (control), H2O2 (100 mM) or TMZ (300 mM). (A)
Representative histograms of flow cytometric analysis of MitoSox
fluorescence. (B) Columns represent the CM-CFDA-mean fluorescence.
Data are expressed as means 6 S.E. of three independent experiments.
p,0.001 (***).
doi:10.1371/journal.pone.0024665.g004
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conditions of oxidative stress generate substantially less ROS,
reduce states 2 and 4 of mitochondrial respiration, and overall,
reduce cardiolipin oxidation and DNA oxidation as measured by
the formation of AP sites in mtDNA. One possible explanation is
decreased complex I activity and/or increased CcO activity [18].
Indeed,itispredictedthat decreasedactivityofcomplex I combined
with increased activity of complexes II-III and CcO may increase
ETC efficiency, decrease mitochondrial proton and electron leak,
and decrease the generation of mtROS. This may be particularly
relevant as ROS are primarily generated at complex I of the ETC,
with CcO not normally directly involved in ROS generation.
Increased CcO activity would, however, confer an increased
capacity for electron flux through the ETC which, in turn, would
lead to an decreased ROS formation. This mechanism could be a
part of a previously unrecognized adaptive chemoresistance
mechanism that links both oxidative stress and drug resistance in
cancer cells, leading to suppressed apoptotic signaling [27].
Our results point to tighter mitochondrial coupling and higher
efficiency of mitochondrial metabolism in the UTMZ cells, as
shown by an increase in state 3 respiration and an increase in the
RCR and ACR ratios. Indeed, in these cells, both glucose
consumption and lactate production are lower than in TMZ-
sensitive U251 cells. To our knowledge, this is the first report of a
bioenergetics profile of isolated chemoresistant mitochondria
cancer cells. Together, our data pointed toward a better
mitochondrial efficiency and a reversed ‘‘Warburg effect.’’ The
coupling (or uncoupling) state of mitochondria is a key component
of mitochondrial respiratory control. While resting (state 2)
respiration was decreased in UTMZ cells, ADP-stimulated (state
3) coupled respiration was significantly increased to levels similar
to those described in normal muscle and brain tissues [28,29].
Importantly, TMZ-resistant GBM xenolines established directly
from human GBM tumor tissues exhibited a similar respiration
profile including tight mitochondrial coupling and high efficiency
of mitochondrial metabolism.
Figure 5. Determination of GSH/GSSG ratio, lipid peroxidation and AP sites generation. (A) GSH/GSSG ratio in U251 and UTMZ cells under
control conditions or after treatment with 100 mMH 2O2 for 1 h. (B) Generation of AP sites in mitochondrial DNA from U251 and UTMZ cells treated for
1 h with 100 mMH 2O2. Columns represent the number of AP sites relative to the control. Data are expressed as means 6 S.E. of three independent
experiments. (C,D) Effect of H2O2 and TMZ on cardiolipin oxidation. (C) Representative histograms of flow cytometric analysis of NAO fluorescence,
(D) Columns represent the NAO-mean fluorescence. Data are expressed as means 6 S.E. of three independent experiments. p,0.05 (*), p,0.01 (**)
and p,0.001 (***). (E) Representative images acquired with epifluorescence microscopy showing co-localization of Mito Tracker Red and NAO
fluorescence in U251 (Top panel) and UTMZ cells (Bottom panel).
doi:10.1371/journal.pone.0024665.g005
Mitochondrial Function and Chemoresistance
PLoS ONE | www.plosone.org 6 September 2011 | Volume 6 | Issue 9 | e24665Otto Warburg observed that cancer cells are often characterized
by intense glycolysis in the presence of O2 and a concomitant
decrease in mitochondrial [15–17]. While mitochondrial dysfunc-
tion has long been reported to contribute to cancer development,
one possible explanation for our findings may be that cancer cells
that survive a genotoxic stress can engage their ‘‘remodeled’’ ETC
to survive. Due to the profound changes identified in the ETC of
TMZ-resistant cells, we speculate that chemoresistant cells might
result primarily from the selection of TMZ-resistant cells, in which
ROS production was suppressed before initiation of the TMZ
challenge, already existing in the original polyclonal population.
However, the importance of clonal selection in the development of
TMZ resistance of gliomas remains to be elucidated.
These results have led us to develop a central hypothesis that
decreased glucose entry and lactate production can control the
amount of reducing equivalents to the ETC, resulting in lower
ROS production, particularly O2
2, through the ETC. This
regulatory mechanism at the level of the mitochondria may be
extremely efficient and relevant in chemoresistant glioma cells,
since genotoxic stressors such as DNA alkylating agents rely on
ROS production to work [14,30]. Additionally, the observation
that FCCP greatly decreases ROS production suggests that
anything that accelerates the movement of electrons down the
ETC would decrease mtROS generation by depleting the
electron-rich intermediates. In support of this, we previously
showed that the activities of complexes II–III and CcO are
substantially higher in UTMZ cells than in U251 cells [18].
Enhanced activities of these complexes might well cause depletion
of electron-rich intermediates in the ETC in UTMZ cells.
Our data indicate that interference in the cellular redox balance
can be exploited to overcome chemoresistance in glioma. We used
ROS scavengers to eliminate the contribution of ROS to TMZ-
induced apoptosis. Treatment with NAC greatly suppressed TMZ-
induced apoptosis in U251 cells. On the other hand, in UTMZ
cells that had an enhanced anti-oxidant capacity (GSH/GSSG
ratio) after treatment with BSO, as compared to U251 cells,
showed improvement in TMZ-sensitivity and apoptosis. Both of
these data support the involvement of a redox-sensitive mechanism
in chemoresistance.
Mitochondrial DNA-depleted (ru) mammalian cells and their
cybrids have provided valuable cell models for studying important
functions of mitochondria such as OxPhos, ATP production,
electron transport, and ROS generation [24,31–33]. ru cells lack a
Figure 6. Determination of ROS production and apoptosis in
cellular models of mitochondrial dysfunction. ROS production was
estimated by oxidation of the fluorescent probes MitoSox in U251, U251-
ru and U251-ru cybrid cells, and in COX-IV-1-shRNA transfected versus
control, empty vector-transfected UTMZ cells (pLKO.1), in control vehicle-
treated (control) cells or after 2 h of treatment with TMZ (300 mM). (A)
Columns represent the MitoSox-mean fluorescence. (B) Quantification of
apoptosis activation in different cellular models of mitochondrial
dysfunction 72 h after treatment with TMZ (300 mM). Columns represent
the average from triplicate determinations of the percentage of
apoptotic cells. Data are expressed as means 6 S.E. for three
independent experiments. p,0.05 (*), p,0.01 (**) and p,0.001 (***).
doi:10.1371/journal.pone.0024665.g006
Figure 7. Effect of NAC and BSO on ROS production and TMZ-
dependent apoptosis. (A) U251 and (B) UTMZ cells were treated with
NAC (5 mM) or BSO (5 mM) for 24 h. Apoptotic cells were examined by
Annexin V/Pi staining. Columns represent the average from triplicate
determinations of the percentage of apoptotic cells. Data are presented
as mean 6 S.E. (n=3). p,0.05 (*), p,0.01 (**) and p,0.001 (***)).
doi:10.1371/journal.pone.0024665.g007
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the mitochondrial level [24,34]. We reasoned that the non-
functional mitochondria of U251-ru cells would affect the outcome
of the cells after treatment with TMZ. Consistent with our
hypothesis, U251-ru cells showed resistance to TMZ, and lower
mitochondrial O2
2 levels were also observed after TMZ
treatment. When U251-ru cells were repopulated with mitochon-
dria from U251 cells, these trans-mitochondrial cybrids recovered
both their sensitivity to TMZ and ROS production. Overall, our
results support the general idea that TMZ-sensitivity arises from
enhanced production of ROS from electron-rich intermediates of
the mitochondrial ETC. The TMZ-resistant UTMZ cells were
found to have significantly less ROS production, and this was
associated with enhanced chemoresistance. Accordingly, in our
CcO knockout cellular model, besides the decrease in CcO activity
and a parallel increase in the sensitivity to TMZ [18], we found an
enhanced mtROS production under TMZ challenge.
Our data support an integrated model of chemoresistant and
chemosensitive glioma where mitochondrial metabolism plays a
central role (Fig. 8). In this model, glioma cells with a glycolytic
phenotype buttheability toswitch toOxPhos metabolism[19,35–38]
are sensitive to chemotherapy, and because they have dysfunctional
mitochondria, mtROS is produced in excess. This endpoint is
essential for compounds such as TMZ to be active (Fig. 8, Model A).
Many anticancer drugs induce oxidative stress either as a direct
mechanism of cell death or as an indirect effect of exposure, as
observed with several chemotherapeutic agents [39]. Model B and C
(Fig. 8) represent chemoresistant cells, with opposite bioenergetic
phenotypes. Model B depicts cells that are exclusively glycolytic and
unable to switch to OxPhos. Thus, these cells have low mtROS levels
and illustrate more of the Pasteur Effect than the Warburg Effect
demonstrated in Model A. An experimental model of these cells is
represented by the mtDNA-depleted cancer cells used by us and
other groupsand described to bechemoresistant (Fig. 6) [40–42]. The
opposite bioenergetic profile, illustrated in Model C, relies on a tight
and efficient mitochondrial OxPhos pathway, which results from
remodeling of the ETC, including decreased activity of Complex I
and increased activities of Complexes II–III and CcO [18]. These
cells, as demonstrated in this study, have low mtROS production and
are resistant to oxidative stress. A similar mechanism has been
previously reported for O2-tolerance in HeLa cells. Resistance to
hyperoxia was found to be associated with increased mitochondrial
efficiency and low mtROS production [43].
While Models B and C represent cells with opposite
bioenergetic phenotypes, both have low mtROS levels, and
consequently, both are chemoresistant. Indeed, pathways involved
in the ROS-adaptive response could play a critical role in
protecting cells against cytotoxic effects of anticancer agents, thus
supporting the hypothesis of a correlation between adaptation to
oxidative stress, low mtROS production and resistance to
anticancer drugs [44]. Whether Models B and C describe pre-
existing cells present within the bulk of the tumor (Model A) or
cells that are transformed through chemotherapeutic treatment,
the data presented here strongly indicate that chemoresistance in
glioma is linked to low mtROS production and improved
mitochondrial function. Moreover, combining pro-oxidant thera-
py with standard of care chemotherapy could be an effective
strategy to overcome chemoresistance.
Materials and Methods
Cell culture
The human glioma cell line, U251, was kindly provided by Dr.
Darell D. Bigner, Duke University, Durham, NC. TMZ-sensitive
U251 cells, their TMZ-resistant counterparts (UTMZ) [18] and
transmitochondrial cybrids [24] were grown in DMEM/F-12
medium plus L-glutamine supplemented with 7% heat-inactivated
FBS, penicillin, and streptomycin. U251-ru cells [24] were
Figure8.Mitochondrialregulationofchemosensitiveandchemoresistanceingliomacells.(A)GlycolyticcellswithfunctionalOxPhos(Warburg
effect) and high mtROS. (B) Exclusively glycolytic cells (Pasteur effect) and no mtROS production. (C) OxPhos cells with tight coupling and low mtROS.
doi:10.1371/journal.pone.0024665.g008
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pyruvate and 50 mg/ml uridine. Cells were incubated at 37uCi na
humidified atmosphere containing 5% CO2.
Primary and TMZ-resistant GBM Xenograft Lines
The establishment and maintenance of the Mayo GBM
xenograft panel has been described [45]. Briefly, TMZ resistance
models were developed by subjecting mice with established flank
tumors to successively higher doses of TMZ until tumor growth
was no longer inhibited by 120 mg/kg/day TMZ for 5 days [44].
The resulting TMZ-resistant lines were maintained by serial
passage. The efficacy of TMZ (66 mg/kg/day 65 days) in
orthotopic xenografts was evaluated as described [46].
High resolution respirometry
Preparation of mitochondria was performed as previously
described [18]. The integrity of the outer mitochondrial membrane
was tested by addition of exogenous cytochrome c (cyt c) [47,48].
The stimulatory effect of cyt c on O2 flux rates was lower than 5%,
indicative of high quality mitochondrial preparations. Mitochon-
drial respiration assays using freshly isolated mitochondria were
performed by measuring O2 consumption in a two-channel
respirometer (Oxygraph-2k with DatLab software; Oroboros
Instruments, Innsbruck, Austria) as previously described [47,49].
Respiration rates were measured using a multisubstrate/inhibition
protocol with saturating concentrations of substrates and inhibitors
added consecutively. State 2 respiration was measured after the
addition of 10 mM glutamate and 5 mM malate. Coupled
respiration (state 3) was determined after the addition of 1 mM
ADP, and state 4 (respiration not coupled to ATP synthesis)
respiration was measured after the consumption of ADP. An
induced state 4 (state 4i) respiration rate was established after the
addition of 2 mg/ml oligomycin, followed by evaluation of maximal
ETC capacity with a titration of the chemical uncoupler
carbonylcyanide-4-(trifluoromethoxy)-phenylhydrazone (FCCP).
Next, the following additions were made: 1 mM rotenone to inhibit
the electron flow from complex I, 10 mM antimycin A to inhibit
electron flow from complex II to cyt c, and 0.5 mM tetramethyl-
phenylene diamine (TMPD) with 2 mM ascorbate to activate CcO.
Glucose uptake
Uptake experiments were carried out as previously described
[19] using 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deox-
yglucose (2-NBDG) (Invitrogen, Carlsbad, CA).
Lactate production
Lactate accumulation in the culture medium was determined
using a fluorescence-lactate assay kit from Cayman (Ann Arbor,
MI), according to the manufacturer’s instructions.
Estimation of ROS production
Intracellular ROS production was determined by measuring the
levels of O2
2 and H2O2 produced in the cells by flow cytometry after
staining the cells with CM-CFDA or MitoSOX
TM Red (Invitrogen,
Carlsbad, CA) as previously described [50]. Briefly, 0.3610
6 cells
were plated in each well of six well plates and allowed to attach
overnight, then exposed to either H2O2 or TMZ for varying time
periods. Cells were further incubated with MitoSOX
TM Red (2 mM)
or CM-CFDA (5 mM) at 37uC for 25 min. Subsequently, cells were
removed, washed and resuspended in PBS and analyzed for ROS
production using a flow cytometer. Approximately 20,000 cells were
evaluated for each sample. In all determinations, cell debris and
clumps were excluded from the analysis.
Imaging of NAO and MitoSox fluorescence
Cells were cultured on 12 mm glass cover slides. After treatment
with vehicle or TMZ (300 mM, 2 h), cells were incubated with
MitoSOX Red (2 mM) or NAO (0.2 mM) for 15 min and
subsequently incubated with MitoTracker (0.2 mM) for 15 min
before being imaged. Cells were washed and mounted in
ProLongH Gold antifade reagent with DAPI (Invitrogen) and
viewed with a Leica/Leitz DMRB fluorescence microscope
equipped with appropriate excitation and emission filter sets
(Chromatechnology). Images were acquired with a C5810 series
digital color camera (Hamamatsu Photonic System). Images were
processed with CorelH PaintShop PhotoH Pro X3 Ultimate.
Determination of apoptosis
The apoptosis-inducing effects of TMZ in U251, UTMZ,
U251-r
0, transmitochondrial cybrids, and COXIV-1-shRNA cells
were determined by flow cytometery using annexin-V/7AAD as
described previously [18]. About 0.1610
6 cells were plated in each
well of 12-well plate and treated with 300 mM TMZ for 72 h.
Apoptosis was determined using the PE Annexin V Apoptosis
Detection Kit (BD Pharmigen), according to manufacturer’s
instructions, and analyzed by flow cytometry using a FACSCalibur
(Becton Dickinson Biosciences) and FlowJo software from Tree
Star.
Estimation of AP sites in mtDNA
AP sites of DNA lesions were analyzed as we described
previously [51]. Mitochondrial and genomic DNA were purified
as we previously described [18,24]. The number of AP sites was
assessed using a DNA damage quantification kit (Abcam, Cam-
bridge, MA) according to the manufacturer’s instructions.
Determination of oxidative damage to mitochondrial
membrane
Mitochondrial membrane lipid peroxidation was detected by
measuring the oxidation of intracellular cardiolipin, using 10-N-
nonyl Acridine Orange (NAO) (Molecular Probes), a probe
specific for mitochondrial membrane cardiolipin [5]. Briefly, cells
were incubated for 1–3 h with 100 mMH 2O2 or 300 mM TMZ,
washed and then incubated with 2 mM NAO for 25 min at room
temperature. After being washed with PBS, the cells were analyzed
by flow cytometry. Approximately 20,000 cells were evaluated for
each sample, and forward scatter versus side scatter was used to
gate the viable population of cells. In all determinations, cell debris
and clumps were excluded from the analysis.
Determination of GSH and GSSG levels
GSH and GSSG levels were determined in glioma cells using a
Bioxytech GSH/GSSG-412 kit according to the instructions of the
manufacturer (OxisResearch, Portland, OR) as we described
previously [50].
Statistics
Data were evaluated using GraphPad. All reported pvalues are two-
sided t-test,a n dp values of less than 0.01 were considered to indicate
statistical significance. Experiments were performed in triplicate and
were performed twice or more to verify the results. Data are shown as
the means 6 S.E. p,0.05 (*), p,0.01 (**) and p,0.001 (***).
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